Vifor Pharma AG VIF.N-CH:Swiss Exchange

*Data is delayed | CHF
Last | 1:00 PM CEST
169.20quote price arrow up+0.25 (+0.15%)
Volume
1,283
52 week range
102.30 - 197.20
Loading...
  • Open169.35
  • Day High169.50
  • Day Low169.00
  • Prev Close168.95
  • 52 Week High197.20
  • 52 Week High Date05/20/22
  • 52 Week Low102.30
  • 52 Week Low Date11/30/21

Key Stats

  • Market Cap11,650.8M
  • Shares Out64.89M
  • 10 Day Average Volume-
  • Dividend2.00
  • Dividend Yield1.18%
  • Beta-
  • YTD % Change-

KEY STATS

  • Open169.35
  • Day High169.50
  • Day Low169.00
  • Prev Close168.95
  • 52 Week High197.20
  • 52 Week High Date05/20/22
  • 52 Week Low102.30
  • 52 Week Low Date11/30/21
  • Market Cap11,650.8M
  • Shares Out64.89M
  • 10 Day Average Volume-
  • Dividend2.00
  • Dividend Yield1.18%
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)2.22
  • P/E (TTM)76.22
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vifor Pharma AG

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vifor Pharma AG, formerly known as Galenica AG, is a Switzerland-based company engaged in the healthcare market. The Company operates through a single pharmaceutical segment. It develops, manufactures and markets pharmaceutical products, specializing in therapies for iron deficiency, nephrology and cardio-renal diseases. The Company's portfolio of iron deficiency treatments includes intravenous products, Ferinject and Venofer, and oral product, Maltofer, among others. Its...
Jacques Theurillat
Independent Chairman of the Board of Directors
Abbas Hussain
Chief Executive Officer
Address
Rechenstrasse 37
St. Gallen
9014
Switzerland